2024-2028年全球經皮吸收貼片市場

經皮吸收貼片市場預計在 2023 年至 2028 年期間將成長 20 億美元，預測期內複合年成長率為 5.65%。

該報告包括對經皮吸收貼片市場的總體分析、市場規模/預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。由於對非侵入性給藥方法的需求不斷成長、慢性病患病率不斷上升以及經皮吸收貼片開發投資的增加，醫療保健支出不斷成長，推動了市場的發展。

這項研究認為，提高藥物輸送效率的微針貼片市場的開拓是未來幾年推動經皮吸收貼片市場成長的關鍵因素之一。此外，經皮吸收貼片在皮膚科和化妝品領域的廣泛應用以及貼片製造中永續和生物分解性材料的採用將帶來巨大的市場需求。

目錄

第1章執行摘要

• 市場概況

第2章 市場狀況

• 市場生態系統

第3章 市場規模評估

• 市場定義
• 細分市場分析
• 2023 年市場規模
• 2023-2028年市場展望

第4章 市場規模表現

• 2018-2022年全球經皮吸收貼片市場
• 2018-2022 年按應用分類的細分市場分析
• 2018-2022 年最終用戶細分分析
• 2018-2022 年區域細分分析

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第6章市場區隔：按應用

• 細分市場
• 比較：按應用
• 疼痛管理：2023-2028 年市場規模與預測
• 中樞神經系統疾病：2023-2028 年市場規模與預測
• 荷爾蒙管理：2023-2028 年市場規模與預測
• 心血管疾病：2023-2028 年市場規模與預測
• 其他：2023-2028年市場規模與預測
• 市場機會：依應用分類

第7章市場區隔：依最終用戶

• 細分市場
• 比較：按最終用戶
• 居家照護：2023-2028 年市場規模與預測
• 醫院與診所：2023-2028 年市場規模與預測
• 市場機會：依最終用戶分類

第8章 客戶狀況

• 客戶狀況概覽

第9章 地區情勢

• 區域細分
• 區域比較
• 北美：2023-2028 年市場規模與預測
• 歐洲：2023-2028 年市場規模與預測
• 亞洲：2023-2028年市場規模與預測
• 世界其他地區：2023-2028 年市場規模與預測
• 美國：2023-2028 年市場規模與預測
• 中國：2023-2028年市場規模及預測
• 德國：2023-2028 年市場規模與預測
• 英國：2023-2028 年市場規模與預測
• 日本：2023-2028年市場規模與預測
• 市場機會：按地區

第 10 章 促進因素、挑戰與趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第11章 供應商情況

• 概述
• 供應商情況
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• Agile Therapeutics Inc.
• Alvogen Iceland ehf
• Bayer AG
• Boehringer Ingelheim International GmbH
• Endo International Plc
• Hisamitsu Pharmaceutical Co. Inc.
• IontoPatch
• Johnson and Johnson Services Inc.
• Lead Chemical Co. Ltd.
• Luye Pharma Group Ltd.
• Nitto Denko Corp.
• Novartis AG
• Purdue Pharma LP
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第13章附錄

The transdermal patches market is forecasted to grow by USD 2.00 bn during 2023-2028, accelerating at a CAGR of 5.65% during the forecast period. The report on the transdermal patches market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for non-invasive drug delivery methods, increasing prevalence of chronic diseases, and rising healthcare expenditure owing to increasing investment in transdermal patch development.

Technavio's transdermal patches market is segmented as below:

By Application

• Pain management
• Central nervous system disorders
• Hormonal application
• Cardiovascular diseases
• Others

By End-user

• Homecare
• Hospitals and clinics

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of microneedle patches for enhanced drug delivery efficiency as one of the prime reasons driving the transdermal patches market growth during the next few years. Also, the expansion of transdermal patch applications into dermatological and cosmetic fields and the adoption of sustainable and biodegradable materials in patch manufacturing will lead to sizable demand in the market.

The report on the transdermal patches market covers the following areas:

• Transdermal patches market sizing
• Transdermal patches market forecast
• Transdermal patches market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal patches market vendors that include Alvogen Iceland ehf, Boehringer Ingelheim International GmbH, Endo International Plc, Hisamitsu Pharmaceutical Co. Inc., IontoPatch, Johnson and Johnson Services Inc., Lead Chemical Co. Ltd., Luye Pharma Group Ltd., Medherant Ltd., Mundipharma International Ltd., Nitto Denko Corp., Novartis AG, Purdue Pharma LP, Sparsha Pharma International Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., AdhexPharma SAS, Agile Therapeutics Inc., Bayer AG, and Evernow Inc. Also, the transdermal patches market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global transdermal patches market 2018 - 2022
• 4.2 Application Segment Analysis 2018 - 2022
• 4.3 End User Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Application

• 6.1 Market segments
• 6.2 Comparison by Application
• 6.3 Pain management - Market size and forecast 2023-2028
• 6.4 Central nervous system disorders - Market size and forecast 2023-2028
• 6.5 Hormonal application - Market size and forecast 2023-2028
• 6.6 Cardiovascular diseases - Market size and forecast 2023-2028
• 6.7 Others - Market size and forecast 2023-2028
• 6.8 Market opportunity by Application

7 Market Segmentation by End-user

• 7.1 Market segments
• 7.2 Comparison by End-user
• 7.3 Homecare - Market size and forecast 2023-2028
• 7.4 Hospitals and clinics - Market size and forecast 2023-2028
• 7.5 Market opportunity by End-user

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 China - Market size and forecast 2023-2028
• 9.9 Germany - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity by geography

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Agile Therapeutics Inc.
• 12.4 Alvogen Iceland ehf
• 12.5 Bayer AG
• 12.6 Boehringer Ingelheim International GmbH
• 12.7 Endo International Plc
• 12.8 Hisamitsu Pharmaceutical Co. Inc.
• 12.9 IontoPatch
• 12.10 Johnson and Johnson Services Inc.
• 12.11 Lead Chemical Co. Ltd.
• 12.12 Luye Pharma Group Ltd.
• 12.13 Nitto Denko Corp.
• 12.14 Novartis AG
• 12.15 Purdue Pharma LP
• 12.16 Teva Pharmaceutical Industries Ltd.
• 12.17 Viatris Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global transdermal patches market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - End User Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Five forces analysis - Comparison between 2023 and 2028
• Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits28: Chart on Market condition - Five forces 2023 and 2028
• Exhibits29: Chart on Application - Market share 2023-2028 (%)
• Exhibits30: Data Table on Application - Market share 2023-2028 (%)
• Exhibits31: Chart on Comparison by Application
• Exhibits32: Data Table on Comparison by Application
• Exhibits33: Chart on Pain management - Market size and forecast 2023-2028 ($ billion)
• Exhibits34: Data Table on Pain management - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Chart on Pain management - Year-over-year growth 2023-2028 (%)
• Exhibits36: Data Table on Pain management - Year-over-year growth 2023-2028 (%)
• Exhibits37: Chart on Central nervous system disorders - Market size and forecast 2023-2028 ($ billion)
• Exhibits38: Data Table on Central nervous system disorders - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Chart on Central nervous system disorders - Year-over-year growth 2023-2028 (%)
• Exhibits40: Data Table on Central nervous system disorders - Year-over-year growth 2023-2028 (%)
• Exhibits41: Chart on Hormonal application - Market size and forecast 2023-2028 ($ billion)
• Exhibits42: Data Table on Hormonal application - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Chart on Hormonal application - Year-over-year growth 2023-2028 (%)
• Exhibits44: Data Table on Hormonal application - Year-over-year growth 2023-2028 (%)
• Exhibits45: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
• Exhibits46: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
• Exhibits47: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
• Exhibits48: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
• Exhibits49: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits50: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits51: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits52: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits53: Market opportunity by Application ($ billion)
• Exhibits54: Data Table on Market opportunity by Application ($ billion)
• Exhibits55: Chart on End-user - Market share 2023-2028 (%)
• Exhibits56: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits57: Chart on Comparison by End-user
• Exhibits58: Data Table on Comparison by End-user
• Exhibits59: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
• Exhibits60: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
• Exhibits61: Chart on Homecare - Year-over-year growth 2023-2028 (%)
• Exhibits62: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
• Exhibits63: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibits64: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• Exhibits66: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• Exhibits67: Market opportunity by End-user ($ billion)
• Exhibits68: Data Table on Market opportunity by End-user ($ billion)
• Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits70: Chart on Market share by geography 2023-2028 (%)
• Exhibits71: Data Table on Market share by geography 2023-2028 (%)
• Exhibits72: Chart on Geographic comparison
• Exhibits73: Data Table on Geographic comparison
• Exhibits74: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits75: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits77: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits79: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits81: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits83: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits85: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits87: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits89: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits91: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits93: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits95: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits97: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits99: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits101: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits102: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits103: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits104: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits105: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits107: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits108: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits109: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits110: Market opportunity by geography ($ billion)
• Exhibits111: Data Tables on Market opportunity by geography ($ billion)
• Exhibits112: Impact of drivers and challenges in 2023 and 2028
• Exhibits113: Overview on Criticality of inputs and Factors of differentiation
• Exhibits114: Overview on factors of disruption
• Exhibits115: Impact of key risks on business
• Exhibits116: Vendors covered
• Exhibits117: Matrix on vendor position and classification
• Exhibits118: Agile Therapeutics Inc. - Overview
• Exhibits119: Agile Therapeutics Inc. - Product / Service
• Exhibits120: Agile Therapeutics Inc. - Key offerings
• Exhibits121: Alvogen Iceland ehf - Overview
• Exhibits122: Alvogen Iceland ehf - Product / Service
• Exhibits123: Alvogen Iceland ehf - Key offerings
• Exhibits124: Bayer AG - Overview
• Exhibits125: Bayer AG - Business segments
• Exhibits126: Bayer AG - Key news
• Exhibits127: Bayer AG - Key offerings
• Exhibits128: Bayer AG - Segment focus
• Exhibits129: Boehringer Ingelheim International GmbH - Overview
• Exhibits130: Boehringer Ingelheim International GmbH - Business segments
• Exhibits131: Boehringer Ingelheim International GmbH - Key news
• Exhibits132: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits133: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits134: Endo International Plc - Overview
• Exhibits135: Endo International Plc - Business segments
• Exhibits136: Endo International Plc - Key news
• Exhibits137: Endo International Plc - Key offerings
• Exhibits138: Endo International Plc - Segment focus
• Exhibits139: Hisamitsu Pharmaceutical Co. Inc. - Overview
• Exhibits140: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
• Exhibits141: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
• Exhibits142: IontoPatch - Overview
• Exhibits143: IontoPatch - Key offerings
• Exhibits144: Johnson and Johnson Services Inc. - Overview
• Exhibits145: Johnson and Johnson Services Inc. - Business segments
• Exhibits146: Johnson and Johnson Services Inc. - Key news
• Exhibits147: Johnson and Johnson Services Inc. - Key offerings
• Exhibits148: Johnson and Johnson Services Inc. - Segment focus
• Exhibits149: Lead Chemical Co. Ltd. - Overview
• Exhibits150: Lead Chemical Co. Ltd. - Product / Service
• Exhibits151: Lead Chemical Co. Ltd. - Key offerings
• Exhibits152: Luye Pharma Group Ltd. - Overview
• Exhibits153: Luye Pharma Group Ltd. - Business segments
• Exhibits154: Luye Pharma Group Ltd. - Key offerings
• Exhibits155: Luye Pharma Group Ltd. - Segment focus
• Exhibits156: Nitto Denko Corp. - Overview
• Exhibits157: Nitto Denko Corp. - Business segments
• Exhibits158: Nitto Denko Corp. - Key offerings
• Exhibits159: Nitto Denko Corp. - Segment focus
• Exhibits160: Novartis AG - Overview
• Exhibits161: Novartis AG - Business segments
• Exhibits162: Novartis AG - Key news
• Exhibits163: Novartis AG - Key offerings
• Exhibits164: Novartis AG - Segment focus
• Exhibits165: Purdue Pharma LP - Overview
• Exhibits166: Purdue Pharma LP - Product / Service
• Exhibits167: Purdue Pharma LP - Key offerings
• Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits173: Viatris Inc. - Overview
• Exhibits174: Viatris Inc. - Business segments
• Exhibits175: Viatris Inc. - Key news
• Exhibits176: Viatris Inc. - Key offerings
• Exhibits177: Viatris Inc. - Segment focus
• Exhibits178: Inclusions checklist
• Exhibits179: Exclusions checklist
• Exhibits180: Currency conversion rates for US$
• Exhibits181: Research methodology
• Exhibits182: Validation techniques employed for market sizing
• Exhibits183: Information sources
• Exhibits184: List of abbreviations